Trial Profile
A double-blind, placebo-controlled, pilot study evaluating adjunctive quetiapine SR in patients with premenstrual syndrome/premenstrual dysphoric disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Premenstrual dysphoric disorder; Premenstrual syndrome
- Focus Adverse reactions; Therapeutic Use
- 28 Oct 2015 New trial record